Deargen Companies
Deargen provides AI-based genome analysis service.
.png)
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Daejeon, Taejon-jikhalsi, South Korea
Founded Date:
2016-12-06
Investor Type:
N/A
Investment Stage:
N/A
Last Funding Date:
2022-02-24
Total Funding:
19647275.0
Technology:
COVID
Employee Number:
11-50
Number Of Exists:
N/A
Investors Number:
6.0
Industry:
BioTech & Health Care